1.87
전일 마감가:
$1.99
열려 있는:
$1.98
하루 거래량:
279.72K
Relative Volume:
1.70
시가총액:
$96.05M
수익:
$107.88M
순이익/손실:
$-33.52M
주가수익비율:
-2.7877
EPS:
-0.6708
순현금흐름:
$-11.94M
1주 성능:
-6.50%
1개월 성능:
-8.33%
6개월 성능:
-54.61%
1년 성능:
+2.19%
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH vs TMO, DHR, IDXX, WAT, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
MDXH
Mdxhealth Sa
|
1.87 | 102.22M | 107.88M | -33.52M | -11.94M | -0.6708 |
|
TMO
Thermo Fisher Scientific Inc
|
459.30 | 168.20B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
166.26 | 117.86B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
533.92 | 41.97B | 4.45B | 1.10B | 1.06B | 13.59 |
|
WAT
Waters Corp
|
352.21 | 34.17B | 3.77B | 449.25M | 240.68M | 7.8556 |
|
A
Agilent Technologies Inc
|
112.90 | 31.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-17 | 개시 | Craig Hallum | Buy |
| 2024-10-31 | 개시 | Lake Street | Buy |
| 2023-05-31 | 개시 | TD Cowen | Outperform |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
Mdxhealth Sa 주식(MDXH)의 최신 뉴스
MDxHealth SA expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Number of shareholders of MDxHealth SA – NASDAQ:MDXH - TradingView
MSN Money - MSN
MDXH SEC FilingsMdxhealth Sa 10-K, 10-Q, 8-K Forms - Stock Titan
Mdxhealth to Release First Quarter 2026 Financial Results on May 13 - The Manila Times
Mdxhealth schedules May 13 webcast and Q&A for Q1 results - Stock Titan
MDxHealth Sets May 28, 2026 Shareholders’ Meetings to Approve 2025 Accounts and Governance Moves - TipRanks
MDxHealth (NASDAQ: MDXH) seeks approval for 2026 warrants, option plan and authorized capital - Stock Titan
MDxHealth SA (MDXH) Stock: Risk Factors Evaluation (Trend Weakens) 2026-04-27Support Bounce - newser.com
Press Release: Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results - Moomoo
MDxHealth SA (NASDAQ:MDXH) Short Interest Down 73.9% in April - MarketBeat
MDXH MDxHealth SA Q4 2025 earnings miss estimates, 19.8% YoY revenue growth fails to stop 5.19% share drop.Community Sell Signals - Cổng thông tin điện tử tỉnh Tây Ninh
MDXH (MDxHealth SA Ordinary Shares) Q4 2025 revenue grows 19.8 percent year over year, shares rise 1.76 percent despite EPS miss.Dividend Safety - UBND thành phố Hải Phòng
MDxHealth SA (MDXH) Stock: Why It Could Volatile (Recovers) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Sanford Jay Siegel Net Worth (2026) - GuruFocus
Koen Hoffman Net Worth (2026) - GuruFocus
Ron Kalfus Net Worth (2026) - GuruFocus
Joseph Sollee Net Worth (2026) - GuruFocus
Michael Mcgarrity Net Worth (2026) - GuruFocus
Hilde Windels Net Worth (2026) - GuruFocus
MDxHealth (MDXH) director lists 4.7M indirect shares via managed funds - Stock Titan
MDxHealth (NASDAQ: MDXH) CCO reports multi-year share option grants - Stock Titan
MDxHealth (MDXH) CEO discloses 95,000 shares and extensive option grants - Stock Titan
MDxHealth (NASDAQ: MDXH) officer discloses extensive share option awards - Stock Titan
[Form 3] MDxHealth SA Initial Statement of Beneficial Ownership - Stock Titan
Buy Signal: Will MDxHealth SA benefit from green energy policies2026 Decliners & AI Driven Price Forecasts - baoquankhu1.vn
Short Interest in MDxHealth Surges 88.5% - National Today
MDxHealth SA (NASDAQ:MDXH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
MDxHealth (MDXH) director Don Hardison reports 40,000 share options - Stock Titan
MDxHealth (MDXH) director Siegel holds options for 10,000 ordinary shares - Stock Titan
MDxHealth (MDXH) director lists multi-year share option awards - Stock Titan
MDxHealth (NASDAQ: MDXH) director Koen Hoffman details 43,000 share options - Stock Titan
Is MDxHealth SA (MDXH) Stock still in growth phase | MDXH Q4 Earnings: Misses Estimates by $0.04Moat - newser.com
Is MDxHealth SA (MDXH) Stock a Market Leader | Price at $2.13, Down 1.39%Expert Stock Picks - newser.com
MDXH Technical Analysis & Stock Price Forecast - Intellectia AI
Health Catalyst (NASDAQ:HCAT) and MDxHealth (NASDAQ:MDXH) Head to Head Review - Defense World
MDxHealth (NASDAQ: MDXH) highlights losses, debt covenants and risk factors - Stock Titan
MDxHealth SA Auditor Raises 'Going Concern' Doubt - marketscreener.com
Stock List: Research Stocks from Around the World - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest - marketbeat.com
MDXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
MDXH: William Blair to Host Virtual Meeting on March 19 - GuruFocus
MDxHealth (NASDAQ: MDXH) director reports 10,000-share option grant - Stock Titan
MVM Partners (MDXH) discloses indirect stake of 4.7M MDxHealth shares - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 - The Manila Times
Gene test flags prostate cancer patients who may avoid aggressive treatment - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
MDxHealth SA Stock (ISIN: US55278X1072) Gains Momentum on Prostate Cancer Test Momentum - AD HOC NEWS
Mdxhealth Sa (MDXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):